The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

Found 358 results
Filters: Author is Anushka Patel
2014
, Webster RJ, Singh K, Jan S, et al. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. American Heart Journal. 2014;167:127-32.
Patel B, Usherwood T, Harris M, et al. Understanding the impact of a multifaceted quality improvement intervention to improve cardiovascular disease risk management in Australian Primary Health Care: the TORPEDO study process evaluation [poster presentation]. In: World Congress of Cardiology (WCC). World Congress of Cardiology (WCC). Melbourne, Australia; 2014.
2013
Praveen D, Patel A, Macmahon S, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Praveen D, Patel A, Macmahon S, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes mellitus and cardiovascular disease or risk factors: The ADVANCE Study. Diabetes. 2013.
Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013;310(9):918-29. doi:10.1001/jama.2013.277064.
Chalmers J, Arima H, Woodward M, et al. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial. Hypertension. 2013.
Hata J, Arima H, Zoungas S, et al. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLOS ONE. 2013;8.
Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial. Circulation. 2013;128:1325-34.
Stefansdottir G, Zoungas S, Chalmers J, et al. Erratum to : Intensive glucose control and risk of cancer patients with type 2 diabetes. Diabetologia. 2013.
Patel A. Health management and policy aspects of cardiovascular diseases [Invited speaker]. In: Wellcome Trust Frontiers Meeting: The Growing Global Health Burden of Non-Communicable Diseases. Wellcome Trust Frontiers Meeting: The Growing Global Health Burden of Non-Communicable Diseases. London, United Kingdom; 2013.
van Dieren S, Kengne A, Chalmers J, et al. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial. Diabetes, Obesity and Metabolism. 2013.
Perkovic V, Heerspink HL, Chalmers J, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International. 2013;83:517-23.
, Stewart F, Singh K, Laba TL, et al. INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications. BMJ Open. 2013;3.
Batty GD, Li Q, Huxley RR, et al. Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. European Psychiatry. 2013;28:49-52.
Webster RJ, Patel A, Billot L, et al. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration. International Journal of Cardiology. 2013.
Webster RJ, Patel A, Billot L, et al. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration. International Journal of Cardiology. 2013;170:30-5.
Schwartz AM, Henson DE, Patel A. Re: Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black-White Crossover. Journal of the National Cancer Institute. 2013.
Patel A, Skulina C, Woodward M, Clarke P, Li Q, Zoungas S. The effects of patient characteristics and geographical region on hospitalization in patients with Type 2 diabetes. Diabetic Medicine. 2013.
Blomster JI, Chow CK, Zoungas S, et al. The Influence Of Physical Activity On Vascular Complications And Mortality In Patients With Type 2 Diabetes Mellitus. Diabetes, Obesity and Metabolism. 2013.
Blomster J, Chow CK, Zoungas S, et al. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus. Diabetes, Obesity & Metabolism. 2013;15:1008-12.
Stefansdottir G, Zoungas S, Chalmers J, et al. The post hoc use of randomized controlled trials to explore drug associated cancer outcomes: methodological challenges. Current Drug Safety. 2013.
Peiris D, Agaliotis M, Patel B, Patel A. Validation of a general practice audit and data extraction tool. Australian Family Physician. 2013;42:816-9.
2012
Zoungas S, Chalmers J, Ninomiya T, et al.